ResMed Inc. (RSMDF)
OTCMKTS · Delayed Price · Currency is USD
22.00
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT

ResMed Statistics

Total Valuation

ResMed has a market cap or net worth of 35.93 billion. The enterprise value is 35.82 billion.

Market Cap 35.93B
Enterprise Value 35.82B

Important Dates

The last earnings date was Wednesday, April 23, 2025.

Earnings Date Apr 23, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -0.07%
Shares Change (QoQ) -0.18%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 145.69M

Valuation Ratios

The trailing PE ratio is 27.36.

PE Ratio 27.36
Forward PE n/a
PS Ratio 7.16
PB Ratio 6.48
P/TBV Ratio 15.85
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.75, with an EV/FCF ratio of 22.84.

EV / Earnings 27.28
EV / Sales 7.13
EV / EBITDA 19.75
EV / EBIT 22.18
EV / FCF 22.84

Financial Position

The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.15.

Current Ratio 3.41
Quick Ratio 2.06
Debt / Equity 0.15
Debt / EBITDA 0.46
Debt / FCF 0.54
Interest Coverage 139.28

Financial Efficiency

Return on equity (ROE) is 25.81% and return on invested capital (ROIC) is 16.54%.

Return on Equity (ROE) 25.81%
Return on Assets (ROA) 14.01%
Return on Invested Capital (ROIC) 16.54%
Return on Capital Employed (ROCE) 24.33%
Revenue Per Employee 503,159
Profits Per Employee 131,589
Employee Count 9,980
Asset Turnover 0.70
Inventory Turnover 2.09

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +24.29% in the last 52 weeks. The beta is 0.78, so ResMed's price volatility has been lower than the market average.

Beta (5Y) 0.78
52-Week Price Change +24.29%
50-Day Moving Average 25.64
200-Day Moving Average 21.26
Relative Strength Index (RSI) 55.30
Average Volume (20 Days) 169

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 8.54

Income Statement

In the last 12 months, ResMed had revenue of 5.02 billion and earned 1.31 billion in profits. Earnings per share was 8.91.

Revenue 5.02B
Gross Profit 2.98B
Operating Income 1.61B
Pretax Income 1.58B
Net Income 1.31B
EBITDA 1.76B
EBIT 1.61B
Earnings Per Share (EPS) 8.91
Full Income Statement

Balance Sheet

The company has 944.84 million in cash and 839.77 million in debt, giving a net cash position of 105.07 million.

Cash & Cash Equivalents 944.84M
Total Debt 839.77M
Net Cash 105.07M
Net Cash Per Share n/a
Equity (Book Value) 5.55B
Book Value Per Share 37.83
Working Capital 2.27B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.65 billion and capital expenditures -84.16 million, giving a free cash flow of 1.57 billion.

Operating Cash Flow 1.65B
Capital Expenditures -84.16M
Free Cash Flow 1.57B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 59.37%, with operating and profit margins of 32.10% and 26.15%.

Gross Margin 59.37%
Operating Margin 32.10%
Pretax Margin 31.41%
Profit Margin 26.15%
EBITDA Margin 35.14%
EBIT Margin 32.10%
FCF Margin 31.24%

Dividends & Yields

ResMed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 23.14%
Buyback Yield 0.07%
Shareholder Yield 0.07%
Earnings Yield 3.66%
FCF Yield 4.37%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ResMed has an Altman Z-Score of 12.61.

Altman Z-Score 12.61
Piotroski F-Score n/a